Bajaj Healthcare Limited (BAJAJHCARE) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.103x

Based on the latest financial reports, Bajaj Healthcare Limited (BAJAJHCARE) has a cash flow conversion efficiency ratio of 0.103x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs501.85 Million ≈ $5.43 Million USD) by net assets (Rs4.86 Billion ≈ $52.60 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See BAJAJHCARE equity financing ratio to measure how much of total assets are equity-financed.

Bajaj Healthcare Limited - Cash Flow Conversion Efficiency Trend (2011–2026)

This chart illustrates how Bajaj Healthcare Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Bajaj Healthcare Limited (BAJAJHCARE) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Bajaj Healthcare Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Bajaj Healthcare Limited ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Amber International Holding Limited
NASDAQ:AMBR
-0.008x
Jalles Machado S/A
SA:JALL3
0.104x
Rav Bariach 08 Industries Ltd
TA:BRIH
0.051x
Cosmax Nbt Inc
KQ:222040
0.204x
Merit Turizm Yatirim ve Isletme AS
IS:MERIT
0.006x
Servotronics Inc
NYSE MKT:SVT
-0.067x
YFC-BonEagle Electric Co Ltd
TWO:6220
0.174x
vTv Therapeutics Inc
NASDAQ:VTVT
0.102x

Annual Cash Flow Conversion Efficiency for Bajaj Healthcare Limited (2011–2026)

The table below shows the annual cash flow conversion efficiency of Bajaj Healthcare Limited from 2011 to 2026. For the full company profile with market capitalisation and key ratios, see BAJAJHCARE market cap overview.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2026-03-31 Rs5.33 Billion
≈ $57.64 Million
Rs372.23 Million
≈ $4.03 Million
0.070x +663.44%
2025-03-31 Rs4.66 Billion
≈ $50.41 Million
Rs-57.78 Million
≈ $-624.87K
-0.012x -103.74%
2024-03-31 Rs2.78 Billion
≈ $30.10 Million
Rs922.94 Million
≈ $9.98 Million
0.332x +646.11%
2023-03-31 Rs3.68 Billion
≈ $39.76 Million
Rs-223.24 Million
≈ $-2.41 Million
-0.061x -3007.22%
2022-03-31 Rs3.28 Billion
≈ $35.52 Million
Rs6.86 Million
≈ $74.19K
0.002x -98.76%
2021-03-31 Rs2.58 Billion
≈ $27.95 Million
Rs435.58 Million
≈ $4.71 Million
0.169x +24.21%
2020-03-31 Rs1.52 Billion
≈ $16.40 Million
Rs205.75 Million
≈ $2.23 Million
0.136x -30.38%
2019-03-31 Rs1.29 Billion
≈ $13.96 Million
Rs251.69 Million
≈ $2.72 Million
0.195x +33.31%
2018-03-31 Rs1.14 Billion
≈ $12.29 Million
Rs166.14 Million
≈ $1.80 Million
0.146x -37.16%
2017-03-31 Rs990.00 Million
≈ $10.71 Million
Rs230.39 Million
≈ $2.49 Million
0.233x -17.95%
2016-03-31 Rs886.32 Million
≈ $9.59 Million
Rs251.38 Million
≈ $2.72 Million
0.284x -60.35%
2015-03-31 Rs390.72 Million
≈ $4.23 Million
Rs279.51 Million
≈ $3.02 Million
0.715x +29.24%
2014-03-31 Rs315.57 Million
≈ $3.41 Million
Rs174.68 Million
≈ $1.89 Million
0.554x +12.94%
2013-03-31 Rs295.85 Million
≈ $3.20 Million
Rs145.00 Million
≈ $1.57 Million
0.490x +74.79%
2012-03-31 Rs306.41 Million
≈ $3.31 Million
Rs85.92 Million
≈ $929.15K
0.280x +86.89%
2011-03-31 Rs299.91 Million
≈ $3.24 Million
Rs44.99 Million
≈ $486.60K
0.150x --

About Bajaj Healthcare Limited

NSE:BAJAJHCARE India Drug Manufacturers - Specialty & Generic
Market Cap
$120.06 Million
Rs11.10 Billion INR
Market Cap Rank
#18530 Global
#998 in India
Share Price
Rs329.80
Change (1 day)
+0.18%
52-Week Range
Rs274.95 - Rs507.25
All Time High
Rs712.20
About

Bajaj HealthCare Limited, a pharmaceutical company, develops, manufactures, markets, and sells active pharmaceutical ingredient, intermediates, and finished dosage forms and nutraceuticals for pharmaceutical, nutraceuticals, and food industries in India and internationally. The company offers active pharmaceutical ingredient in various therapeutic categories, including anti-diabetic, antibiotic, … Read more